Browsing the "results" Tag

ACADIA Pharmaceuticals Announces Positive Top-line Results from ADVANCE Trial of Pimavanserin as Treatment for Negative Symptoms of Schizophrenia

November 26th, 2019 📆 | 4990 Views ⚑

SAN DIEGO–(BUSINESS WIRE)–Nov 25, 2019– ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), today announced positive top-line results from its ADVANCE study, a

Tagged with: